Envista’s (NYSE:NVST) Q2 CY2026 Sales Beat Estimates
Envista Holdings (NYSE: NVST) reported strong Q2 CY2026 results, surpassing revenue and adjusted EPS expectations. The dental products company achieved 7.1% year-on-year sales growth and a non-GAAP profit significantly above analyst estimates, leading management to raise its full-year Adjusted EPS guidance. Despite a tepid …